Action of MK‐7264 (Gefapixant) at Human P2X3 and P2x2/3 Receptors and in Vivo Efficacy in Models of Sensitisation
British Journal of Pharmacology - United States
doi 10.1111/bph.14677
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 11, 2019
Authors
Publisher
Wiley